| UniProt ID | NAA30_HUMAN | |
|---|---|---|
| UniProt AC | Q147X3 | |
| Protein Name | N-alpha-acetyltransferase 30 | |
| Gene Name | NAA30 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 362 | |
| Subcellular Localization | Cytoplasm . Nucleus . | |
| Protein Description | Catalytic subunit of the N-terminal acetyltransferase C (NatC) complex. Catalyzes acetylation of the N-terminal methionine residues of peptides beginning with Met-Leu-Ala and Met-Leu-Gly. Necessary for the lysosomal localization and function of ARL8B sugeesting that ARL8B is a NatC substrate.. | |
| Protein Sequence | MAEVPPGPSSLLPPPAPPAPAAVEPRCPFPAGAALACCSEDEEDDEEHEGGGSRSPAGGESATVAAKGHPCLRCPQPPQEQQQLNGLISPELRHLRAAASLKSKVLSVAEVAATTATPDGGPRATATKGAGVHSGERPPHSLSSNARTAVPSPVEAAAASDPAAARNGLAEGTEQEEEEEDEQVRLLSSSLTADCSLRSPSGREVEPGEDRTIRYVRYESELQMPDIMRLITKDLSEPYSIYTYRYFIHNWPQLCFLAMVGEECVGAIVCKLDMHKKMFRRGYIAMLAVDSKYRRNGIGTNLVKKAIYAMVEGDCDEVVLETEITNKSALKLYENLGFVRDKRLFRYYLNGVDALRLKLWLR | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 39 | Phosphorylation | GAALACCSEDEEDDE CCCEEECCCCCCCCC | 48.22 | 22167270 | |
| 53 | Phosphorylation | EEHEGGGSRSPAGGE CCCCCCCCCCCCCCC | 32.62 | 30278072 | |
| 55 | Phosphorylation | HEGGGSRSPAGGESA CCCCCCCCCCCCCCC | 22.31 | 29255136 | |
| 61 | Phosphorylation | RSPAGGESATVAAKG CCCCCCCCCCEECCC | 32.30 | 27251275 | |
| 63 | Phosphorylation | PAGGESATVAAKGHP CCCCCCCCEECCCCC | 21.69 | 27251275 | |
| 67 | Ubiquitination | ESATVAAKGHPCLRC CCCCEECCCCCCCCC | 48.27 | - | |
| 67 | Acetylation | ESATVAAKGHPCLRC CCCCEECCCCCCCCC | 48.27 | 25953088 | |
| 89 | Phosphorylation | QQLNGLISPELRHLR HHHCCCCCHHHHHHH | 19.84 | 29255136 | |
| 100 | Phosphorylation | RHLRAAASLKSKVLS HHHHHHHHHHHHHHH | 31.44 | 24719451 | |
| 104 | Acetylation | AAASLKSKVLSVAEV HHHHHHHHHHHHHHH | 45.68 | 26051181 | |
| 107 | Phosphorylation | SLKSKVLSVAEVAAT HHHHHHHHHHHHHCC | 23.44 | 28348404 | |
| 114 | Phosphorylation | SVAEVAATTATPDGG HHHHHHCCCCCCCCC | 13.76 | 29255136 | |
| 115 | Phosphorylation | VAEVAATTATPDGGP HHHHHCCCCCCCCCC | 24.65 | 29255136 | |
| 117 | Phosphorylation | EVAATTATPDGGPRA HHHCCCCCCCCCCCC | 21.59 | 29255136 | |
| 125 | Phosphorylation | PDGGPRATATKGAGV CCCCCCCCCCCCCCC | 35.82 | 24719451 | |
| 127 | Phosphorylation | GGPRATATKGAGVHS CCCCCCCCCCCCCCC | 26.17 | 24719451 | |
| 134 | Phosphorylation | TKGAGVHSGERPPHS CCCCCCCCCCCCCCC | 39.69 | 25159151 | |
| 141 | Phosphorylation | SGERPPHSLSSNART CCCCCCCCCCCCCCC | 35.40 | 20068231 | |
| 143 | Phosphorylation | ERPPHSLSSNARTAV CCCCCCCCCCCCCCC | 25.26 | 20068231 | |
| 144 | Phosphorylation | RPPHSLSSNARTAVP CCCCCCCCCCCCCCC | 39.54 | 24719451 | |
| 148 | Phosphorylation | SLSSNARTAVPSPVE CCCCCCCCCCCCHHH | 29.60 | 30266825 | |
| 152 | Phosphorylation | NARTAVPSPVEAAAA CCCCCCCCHHHHHHH | 34.67 | 30266825 | |
| 160 | Phosphorylation | PVEAAAASDPAAARN HHHHHHHCCHHHHHC | 39.12 | 30266825 | |
| 188 | Phosphorylation | DEQVRLLSSSLTADC HHHHHHHHHHCCCCC | 23.60 | 30266825 | |
| 189 | Phosphorylation | EQVRLLSSSLTADCS HHHHHHHHHCCCCCC | 29.36 | 30266825 | |
| 190 | Phosphorylation | QVRLLSSSLTADCSL HHHHHHHHCCCCCCC | 26.77 | 19664994 | |
| 192 | Phosphorylation | RLLSSSLTADCSLRS HHHHHHCCCCCCCCC | 23.54 | 30266825 | |
| 196 | Phosphorylation | SSLTADCSLRSPSGR HHCCCCCCCCCCCCC | 27.62 | 23401153 | |
| 199 | Phosphorylation | TADCSLRSPSGREVE CCCCCCCCCCCCCCC | 28.80 | 30278072 | |
| 201 | Phosphorylation | DCSLRSPSGREVEPG CCCCCCCCCCCCCCC | 52.29 | 30278072 | |
| 233 | Malonylation | DIMRLITKDLSEPYS HHHHHHHCCCCCCCE | 50.07 | 26320211 | |
| 233 | Acetylation | DIMRLITKDLSEPYS HHHHHHHCCCCCCCE | 50.07 | 19608861 | |
| 276 | Acetylation | VCKLDMHKKMFRRGY HHCHHHCHHHHHHCC | 39.02 | 25953088 | |
| 277 | Acetylation | CKLDMHKKMFRRGYI HCHHHCHHHHHHCCE | 28.70 | 25953088 | |
| 283 | Phosphorylation | KKMFRRGYIAMLAVD HHHHHHCCEEEEECC | 5.45 | 24719451 | |
| 291 | Phosphorylation | IAMLAVDSKYRRNGI EEEEECCCHHHHCCC | 25.61 | 24719451 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of NAA30_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NAA30_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NAA30_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
Oops, there are no PPI records of NAA30_HUMAN !! | ||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-233, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-39; SER-55; THR-117;SER-152; SER-190; SER-196 AND SER-199, AND MASS SPECTROMETRY. | |
| "Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-152, AND MASSSPECTROMETRY. | |